EcoDrugPlus

Ensembl ID : WBGene00221961
Gene Symbol: WBGENE00221961
6 External references
114 Possible Orthologues:

Ensembl ID : WBGene00221964
Gene Symbol: WBGENE00221964
6 External references
72 Possible Orthologues:

Ensembl ID : WBGene00221966
Gene Symbol: WBGENE00221966
6 External references
131 Possible Orthologues:

Ensembl ID : WBGene00221969
Gene Symbol: WBGENE00221969
6 External references
27 Possible Orthologues:

Ensembl ID : WBGene00221972
Gene Symbol: WBGENE00221972
4 External references
47 Possible Orthologues:

Ensembl ID : WBGene00221973
Gene Symbol: WBGENE00221973
4 External references
559 Possible Orthologues:

Ensembl ID : WBGene00221988
Gene Symbol: WBGENE00221988
4 External references
74 Possible Orthologues:

Ensembl ID : WBGene00221995
Gene Symbol: WBGENE00221995
4 External references
826 Possible Orthologues:

Ensembl ID : WBGene00222014
Gene Symbol: WBGENE00222014
4 External references
329 Possible Orthologues:

Ensembl ID : WBGene00222018
Gene Symbol: WBGENE00222018
6 External references
43 Possible Orthologues:

Ensembl ID : WBGene00222026
Gene Symbol: WBGENE00222026
6 External references
118 Possible Orthologues:

Ensembl ID : WBGene00220320
Gene Symbol: WBGENE00220320
3 External references
1193 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).